ATEA PHARMACEUTICALS INC's ticker is AVIR and the CUSIP is 04683R106. A total of 133 filers reported holding ATEA PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 1.03 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $257,159 | -28.1% | 76,764 | +3.3% | 0.00% | – |
| Q4 2022 | $357,547 | +15.3% | 74,334 | +36.4% | 0.00% | – |
| Q3 2022 | $310,000 | -19.1% | 54,492 | +0.8% | 0.00% | – |
| Q2 2022 | $383,000 | +224.6% | 54,042 | +232.2% | 0.00% | – |
| Q1 2022 | $118,000 | -31.4% | 16,270 | -15.5% | 0.00% | – |
| Q4 2021 | $172,000 | -71.8% | 19,261 | +10.7% | 0.00% | – |
| Q3 2021 | $610,000 | +137.4% | 17,398 | +45.2% | 0.00% | – |
| Q2 2021 | $257,000 | – | 11,978 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BML Capital Management, LLC | 5,462,079 | $16,659,341 | 12.62% |
| TANG CAPITAL MANAGEMENT LLC | 4,076,741 | $12,434,060 | 1.15% |
| Stonepine Capital Management, LLC | 839,514 | $2,560,518 | 1.11% |
| Bain Capital Life Sciences Investors, LLC | 2,485,638 | $7,581,196 | 0.73% |
| CM Management, LLC | 270,000 | $823,500 | 0.66% |
| EcoR1 Capital, LLC | 6,995,861 | $21,337,376 | 0.55% |
| Acuitas Investments, LLC | 171,098 | $615,373 | 0.32% |
| Newtyn Management, LLC | 508,474 | $1,550,846 | 0.30% |
| Diametric Capital, LP | 161,524 | $492,648 | 0.30% |
| Auour Investments LLC | 177,000 | $670,830 | 0.26% |